Hepatology

Cover image for Hepatology

December 1993

Volume 18, Issue 6

Pages fmi–fmi, 1293–1546

  1. Masthead

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
    1. You have free access to this content
      Masthead (page fmi)

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180601

  2. Original Articles

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
    1. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection (pages 1293–1299)

      Masayuki Kurosaki, Nobuyuki Enomoto, Fumiaki Marumo and Chifumi Sato

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180602

    2. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2b (pages 1300–1305)

      Giorgio Saracco, Floriano Rosina, Maria Lorena Abate, Livio Chiandussi, Vittorio Gallo, Elena Cerutti, Angelo Di Napoli, Antonio Solinas, Angelo Deplano, Andreina Tocco, Pierangela Cossu, David Chien, George Kuo, Alan Polito, Amy J. Weiner, Michael Houghton, Giorgio Verme, Ferruccio Bonino and Mario Rizzetto

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180603

    3. Monitoring of antiviral therapy with quantitative evaluation of hbeag: A comparison with HBV DNA testing (pages 1306–1312)

      Robert Perrillo, Larry Mimms, Kenneth Schechtman, David Robbins and Carolyn Campbell

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180604

    4. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B (pages 1313–1318)

      Tse-Ling Fong, Adrian M. Di Bisceglie, Michael A. Gerber, Jeanne G. Waggoner and Jay H. Hoofnagle

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180605

    5. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-β (pages 1319–1325)

      Yoshinao Kobayashi, Shozo Watanabe, Masayoshi Konishi, Masato Yokoi, Ryuichi Kakehashi, Masahiko Kaito, Masahiro Kondo, Yuji Hayashi, Takahito Jomori and Shiro Suzuki

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180606

    6. Viral pathogenesis of hepatocellular carcinoma in the United States (pages 1326–1333)

      T. Jake Liang, Lennox J. Jeffers, K. Rajender Reddy, Maria De Medina, I. Talley Parker, Hugo Cheinquer, Victor Idrovo, Alfredo Rabassa and Eugene R. Schiff

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180607

    7. Human leukocyte antigen A1-B8-DR3-DQ2-DPB1*0401 extended haplotype in autoimmune hepatitis (pages 1334–1337)

      Koji Manabe, Peter T. Donaldson, James A. Underhill, Derek G. Doherty, Giorgina Mieli-Vergani, Ian G. McFarlane, Adrian L. W. F. Eddleston and Dr. Roger Williams

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180608

    8. The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. Intravenous drug use (pages 1338–1343)

      Stuart C. Gordon, Richard S. Elloway, John C. Long and Carl F. Dmuchowski

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180609

    9. Interferon-α2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation (pages 1344–1349)

      Noboru Manabe, Michèle Chevallier, Philippe Chossegros, Xavier Causse, Sylviane Guerret, Christian Trépo and Jean-Alexis Grimaud

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180610

  3. Other Clinical Studies

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
    1. Activation of the fibrinolytic system in patients with fulminant liver failure (pages 1350–1356)

      J. Ricardo B. Pernambuco, Peter G. Langley, Robin D. Hughes, Satoru Izumi and Dr. Roger Williams

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180611

    2. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: Immunohistochemical evidence (pages 1357–1362)

      Shotaro Sakisaka, Masahide Watanabe, Hideo Tateishi, Masaru Harada, Satoshi Shakado, Yoshihiro Mimura, Kazuhisa Gondo, Masao Yoshitake, Kazunori Noguchi, Teruko Hino, Ryuichi Nohno, Yasuo Majima, Kenji Hirai, Michio Sata, Hiroshi Yoshida and Kyuichi Tanikawa

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180612

    3. Preneoplastic significance of hepatic iron–free foci in genetic hemochromatosis: A study of 185 patients (pages 1363–1369)

      Yves M. Deugnier, Paul Charalambous, Daniéle Le Quilleuc, Bruno Turlin, Jeffrey Searle, Pierre Brissot, Lawrie W. Powell and June W. Halliday

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180613

    4. The role of transjugular liver biopsy in fulminant liver failure: Relation to other prognostic indicators (pages 1370–1376)

      Bruce W. Donaldson, Ramya Gopinath, Ian R. Wanless, M. James Phillips, Ross Cameron, Eve A. Roberts, Paul D. Greig, Gary Levy and Laurence M. Blendis

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180614

    5. High plasma concentration of myeloperoxidase in cirrhosis: A possible marker of hypersplenism (pages 1377–1383)

      Makoto Nakamuta, Masao Ohashi, Yuichi Tanabe, Kaichiro Hiroshige and Hajime Nawata

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180615

    6. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: Significance of lipoate attachment (pages 1384–1391)

      Janet Quinn, Austin G. Diamond, Jeremy M. Palmer, Margaret F. Bassendine, Oliver F. W. James and Professor Stephen J. Yeaman

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180616

    7. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation (pages 1392–1398)

      Vijayan Balan, Kennetii P. Batts, Michael K. Porayko, Ruud A. F. Krom, Jurgen Ludwig and Russell H. Wiesner

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180617

    8. A prospective study of biliary cytology in 100 patients with bile duct strictures (pages 1399–1403)

      Tomasz R. Kurzawinski, Alastair Deery, James S. Dooley, Robert Dick, Kenneth E. F. Hobbs and Mr. Brian R. Davidson

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180618

    9. Evidence for neurological dysfunction in end-stage protoporphyric liver disease (pages 1404–1409)

      Jeffrey M. Rank, Robert Carithers and Joseph Bloomer

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180619

  4. Laboratory Investigations

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
    1. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures (pages 1437–1442)

      Elke Roeb, Dr. Lutz Graeve, Rolf Hoffmann, Karl Decker, Dylan R. Edwards and Peter C. Heinrich

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180624

    2. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats (pages 1443–1449)

      Kenji Fjuiwara, Sumiko Nagoshi, Akihiko Ohno, Keiichi Hirata, Yasuhiko Ohta, Satoshi Mochida, Tomoaki Tomiya, Kanji Higashio and Kiyoshi Kurokawa

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180625

    3. Increased benzodiazepine-like activity is neither necessary nor sufficient to explain acute hepatic encephalopathy in the thioacetamide-treated rat (pages 1459–1464)

      Peter Widler, Hans U. Fisch, Peter Schoch, Arthur Zimmermann, Thomas E. Schläpfer and Jürg Reichen

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180627

    4. Degradation and intracellular accumulation of a residualizing hyaluronan derivative by liver endothelial cells (pages 1465–1476)

      Carl T. McGary, Judith Yannariello-Brown, Dennis W. Kim, Tami C. Stinson and Paul H. Weige

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180628

    5. Production of chemotactic factor, interleukin-8, from hepatocytes exposed to ethanol (pages 1477–1482)

      Yasushi Shiratori, Hiroshi Takada, Yohko Hikiba, Ryo Nakata, Ken'Ichi Okano, Yutaka Komatsu, Yasuro Niwa, Masayuki Matsumura, Shuichiro Shiina, Masao Omata and Kazuo Kamii

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180629

    6. Increased dietary fat content accelerates cholesterol gallstone formation in the cholesterol-fed prairie dog (pages 1498–1503)

      Wayne W. Lamorte, Daniel P. O'Leary, Michael L. Booker and Thayer E. Scott

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180632

    7. Increase in prostanoid formation in rat liver macrophages (Kupffer cells) by human anaphylatoxin C3a (pages 1516–1521)

      Dr. Gerhard P. Püschel, Ursula Hespeling, Martin Oppermann and Peter Dieter

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180634

  5. Special Articles

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
    1. Cholesterol carriers in human bile: Are “lamellae” involved? (pages 1522–1531)

      David E. Cohen, Eric W. Kaler and Martin C. Carey

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180635

  6. Editorials

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
  7. Hepatology Elsewhere

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
    1. Hepatology elsewhere (pages 1535–1536)

      Jorge J. Gumucio

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180637

  8. Book Reviews

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
  9. Correspondence

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
    1. Of windows, fenestrae and defenestrations (pages 1543–1544)

      Antonio Martinez and Paul D. Berk

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180644

  10. Notices

    1. Top of page
    2. Masthead
    3. Original Articles
    4. Other Clinical Studies
    5. Laboratory Investigations
    6. Special Articles
    7. Editorials
    8. Hepatology Elsewhere
    9. Book Reviews
    10. Correspondence
    11. Notices
    1. Notices (page 1546)

      Version of Record online: 5 DEC 2005 | DOI: 10.1002/hep.1840180646

SEARCH

SEARCH BY CITATION